These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 352331)

  • 21. Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase.
    van der Laan JW; de Boer T; Bruinvels J
    J Neurochem; 1979 Jun; 32(6):1769-80. PubMed ID: 376783
    [No Abstract]   [Full Text] [Related]  

  • 22. Attenuation of brain hyperbaric oxygen toxicity by fasting is not related to ketosis.
    Chavko M; Braisted JC; Harabin AL
    Undersea Hyperb Med; 1999; 26(2):99-103. PubMed ID: 10372429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in primary afferent depolarization after administration of gamma-acetylenic gamma aminobutyric acid (GAG), a gamma-aminobutyric acid (GABA) transaminase inhibitor.
    Larson AA; Anderson EG
    J Pharmacol Exp Ther; 1979 Nov; 211(2):326-30. PubMed ID: 501564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Mohamed M; Czuczwar SJ
    Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnesium sulfate suppresses electroencephalographic manifestations of CNS oxygen toxicity.
    Katz A; Kerem D; Sherman D
    Undersea Biomed Res; 1990 Jan; 17(1):45-9. PubMed ID: 2316059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. gamma-Hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide.
    Hechler V; Ratomponirina C; Maitre M
    J Pharmacol Exp Ther; 1997 May; 281(2):753-60. PubMed ID: 9152382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of sodium dipropylacetate on experimental spike foci.
    Goldensohn ES; Bustamante LA; Lueders H; Pippenger C
    Trans Am Neurol Assoc; 1977; 102():167-9. PubMed ID: 356395
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of flumazenil on CNS oxygen toxicity in the rat.
    Bitterman N; Halpern P
    Methods Find Exp Clin Pharmacol; 1995 Apr; 17(3):169-74. PubMed ID: 8531507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statistical approach to the analysis of sensitivity to CNS oxygen toxicity in rats.
    Benjamini Y; Bitterman N
    Undersea Biomed Res; 1990 May; 17(3):213-21. PubMed ID: 2356591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of antiepileptic action of valproate and ethosuximide in adult and immature rats.
    Mares P; Velisék L
    Pol J Pharmacol Pharm; 1987; 39(5):505-12. PubMed ID: 3147456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CNS oxygen toxicity in oxygen-inert gas mixtures.
    Bitterman N; Laor A; Melamed Y
    Undersea Biomed Res; 1987 Nov; 14(6):477-83. PubMed ID: 3686742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmeningeal delivery of GABA to control neocortical seizures in rats.
    John JE; Baptiste SL; Sheffield LG; von Gizycki H; Kuzniecky RI; Devinsky O; Ludvig N
    Epilepsy Res; 2007 Jun; 75(1):10-7. PubMed ID: 17478079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the substantia nigra in GABA-mediated anticonvulsant actions.
    Gale K
    Adv Neurol; 1986; 44():343-64. PubMed ID: 3010676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nervous system oxygen toxicity during routine hyperbaric oxygen therapy.
    Hampson N; Atik D
    Undersea Hyperb Med; 2003; 30(2):147-53. PubMed ID: 12964858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of drugs acting on the GABA-benzodiazepine receptor complex on flurothyl-induced seizures in Mongolian gerbils.
    Hashimoto Y; Araki H; Suemaru K; Gomita Y
    Eur J Pharmacol; 2006 May; 536(3):241-7. PubMed ID: 16581068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal microinjection of gamma-acetylenic GABA into the rat entorhinal cortex: behavioral and electroencephalographic abnormalities and preferential neuron loss in layer III.
    Wu HQ; Schwarcz R
    Exp Neurol; 1998 Oct; 153(2):203-13. PubMed ID: 9784280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protective effect of the neuropeptide homocarnosine in hyperbaric oxygenation].
    Krichevskaia AA; Bondarenko TI; Makletsova MG; Mikhaleva II
    Vopr Med Khim; 1985; 31(4):75-9. PubMed ID: 4049791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prophylactic and anticonvulsive effects of di--N--propylacetate examined in kindling cat preparations (author's transl)].
    Sato M; Nakashima T; Nagao T; Ohshimo T; Wake A; Tomoda T; Otsuki S
    No To Shinkei; 1977 Dec; 29(12):1267-75. PubMed ID: 339931
    [No Abstract]   [Full Text] [Related]  

  • 39. Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice.
    Löscher W
    Biochem Pharmacol; 1982 Mar; 31(5):837-42. PubMed ID: 6805473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of epileptic responses in the photosensitive baboon, Papio papio, by two irreversible inhibitors of GABA-transaminase, gamma-acetylenic GABA (4-amino-hex-5-ynoic acid) and gamma-vinyl GABA (4-amino-hex-5-enoic acid).
    Meldrum B; Horton R
    Psychopharmacology (Berl); 1978 Sep; 59(1):47-50. PubMed ID: 100812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.